Clinical Trials Directory

Trials / Completed

CompletedNCT00186069

Magnesium Sulfate vs Placebo for Placental Abruption

Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Stanford University · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Detailed description

We hope to learn if there is a difference in the efficacy of intravenous magnesium sulfate versus intravenous saline infusion in the resolution of vaginal bleeding and contractions in patients with a suspected placental abruption.

Conditions

Interventions

TypeNameDescription
DRUGMagnesium SulfateMagnesium Sulfate 4 gram bolus, followed by a maintenance dose at 2 grams per hour. Rate increases up to 4 grams per hour may be administered per physician discretion.
OTHERNormal SalineNormal Saline infusion of 4 gram bolus, followed by 2 grams per hour with rate increases up to 4 grams per hour per physician discretion.

Timeline

Start date
2004-03-01
Primary completion
2014-06-01
Completion
2017-11-01
First posted
2005-09-16
Last updated
2018-01-02
Results posted
2017-04-20

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00186069. Inclusion in this directory is not an endorsement.